Bill
Bill > SB504
NH SB504
NH SB504Relative to the practice of pharmacy and the dispensing of certain medications by pharmacists.
summary
Introduced
11/21/2025
11/21/2025
In Committee
11/21/2025
11/21/2025
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
This bill: I. Authorizes the dispensing of up to a 30-day supply of noncontrolled oral anti-cancer medication by a licensed health care professional legally authorized to prescribe and administer medications to a patient under a provider's care or supervision subject to certain conditions. II. Amends the display requirements of certain licenses and permits. III. Authorizes licensed advanced pharmacy technicians to engage in remote processing. IV. Removes the requirement that a pharmacist's name or initials be on a label affixed to any controlled drug or prescription issued. V. Amends the definition of the "practice of pharmacy." VI. Removes certain authority of the board of pharmacy with respect to the regulation of collaborative pharmacy practice agreements.
AI Summary
This bill introduces several changes to pharmacy practice regulations in New Hampshire. It allows licensed healthcare professionals to dispense up to a 30-day supply of noncontrolled oral anti-cancer medications in a clinic setting, provided the clinic has a full-time pharmacist available for consultation and follows established pharmaceutical standards. The bill modifies license display requirements, shifting from a mandate to display licenses conspicuously to allowing them to be readily retrievable. It expands remote processing capabilities by permitting licensed advanced pharmacy technicians to participate in these activities. The legislation removes the requirement for pharmacists' names or initials on drug labels and broadens the legal definition of "practice of pharmacy" to include a comprehensive range of professional activities such as patient counseling, medication therapy management, and prescribing certain tests and medications. Additionally, the bill removes some of the Board of Pharmacy's regulatory authority regarding collaborative pharmacy practice agreements, simplifying oversight of pharmacists' collaborative practices. These changes aim to modernize pharmacy regulations, increase flexibility for healthcare professionals, and potentially improve patient access to medications and pharmacy services.
Committee Categories
Health and Social Services
Sponsors (3)
Last Action
Health and Human Services Hearing (09:00:00 3/11/2026 Room 100, State House) (on 03/11/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://gc.nh.gov/bill_Status/billinfo.aspx?id=1288&inflect=2 |
| BillText | https://gc.nh.gov/bill_status/legacy/bs2016/billText.aspx?sy=2026&id=1288&txtFormat=html |
Loading...